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Weexaminedgenderandethnicdiﬀerencesintheassociationbetweensleepdisorderedbreathing(SDB)anddiabetesamong6,522
participants aged ≥20 years from the National Health and Nutrition Examination Survey 2005–08. SDB severity was deﬁned based
on an additive summary score including sleep duration, snoring, snorting, and daytime sleepiness. We found that the summary
SDB score was signiﬁcantly associated with diabetes after adjusting for potential confounders in the whole population. Compared
to those without any sleep disturbance, the multivariable odds ratio (OR) (95% conﬁdence interval (CI)) of diabetes among those
with ≥3 sleep disturbances was 2.04 (1.46–2.87). In sex-speciﬁc analyses, this association was signiﬁcant only in women (OR (95%
CI) = 3.68 (2.01–6.72)) but not in men (1.10 (0.59–2.04)), P-interaction = 0.01. However, there were no ethnic diﬀerences in
this association, P-interaction = 0.7. In a nationally representative sample of US adults, SDB was independently associated with
diabetes only in women, but not in men.
1.Introduction
Sleep disordered breathing (SDB) and sleep apnea are
associated with cardiovascular disease [1] and mortality [2].
It has been estimated that approximately 12–18 million
adults are aﬀected by SDB in the USA [3]. Recent studies
conducted in the USA [4–10]a n dE u r o p e[ 11–14]h a v e
shown an association between a variety of markers of SDB
including snoring [4, 11, 15], daytime sleepiness [8, 12, 13],
or sleep duration [5–7, 10, 14] and diabetes. However, some
of these studies used either a single marker of SDB or
were conducted in speciﬁc populations including men [6],
occupational cohorts [4], or older adults [9].
It is not clear if there are gender or ethnic diﬀerences
in the association between SDB and diabetes in the USA.
SDB is often underevaluated and underdiagnosed in women
[16]. Previous studies, mostly conducted in the Europe
[9, 12, 13, 17], have reported gender diﬀerences in the
association between SDB and diabetes. Two of these studies
have reported an association only in women [12, 17] while
one study has reported an association in only men [13]. In
the USA, Enright et al. reported that snoring was associated
with diabetes in older women but not in older men in the
Cardiovascular Health Study [9]. African Americans and
Hispanic Americans were shown to be disproportionately
aﬀected by both sleep disturbances [18] and diabetes [19].
In studies involving predominantly white samples, including
the Sleep Heart Health Study (93% whites) [20] and the
Wisconsin Sleep Cohort Study (96% whites) [21], SDB was
found to be associated with diabetes, whereas SDB was
not associated with diabetes in a predominantly African
American and Hispanic population in a clinical study in
Chicago [22]. In this context, we examined the associa-
tion between several subjective markers of SDB including
snoring, snorting, daytime sleepiness, and sleep duration
and diabetes in a nationally representative sample of US
adults after accounting for depression and other potential
confounders. We also examined the association between2 International Journal of Endocrinology
markers of SDB and diabetes stratiﬁed by gender and race-
ethnicity.
2. Methods
The data for this study is derived from the National Health
and Nutrition Examination Survey (NHANES) 2005-2006
and 2007-2008. Detailed description of NHANES study
design and methods is available elsewhere [23, 24]. In
brief, the NHANES survey included a stratiﬁed multistage
probability sample representative of the civilian noninstitu-
tionalized US population. Selection was based on counties,
blocks, households, and individuals within households, and
included oversampling of non-Hispanic blacks and Mexican
Americans in order to provide stable estimates of these
groups. We restricted our study sample to participants aged
greater than 20 years (age range 20–85 years). Questions
on sleep were ﬁrst included in the NHANES in 2005-
06. Of the 10,914 participants with information on sleep
variables, after excluding those with pregnancy (n = 393),
prevalent cardiovascular disease (n = 1,275), those with
missing information on fasting or nonfasting glucose or
sleep variables (n = 2,109), and those included in the
multivariable model (n = 615), 6,522 were available for the
ﬁnal analysis.
2.1. Outcome of Interest: Diabetes Mellitus. Diabetes was
deﬁned as a serum glucose ≥126mg/dL after fasting for
a minimum of 8 hours, a plasma glucose ≥200mg/dL
for those who fasted <8 hours before their NHANES
visit, or glycosylated hemoglobin (HbA1c) ≥6.5%, a self-
reported physician-diagnosed diabetes or current use of
oral hypoglycemic medication or insulin [25]. Because
NHANESdoesnotcollectinformation(e.g.,c-peptidelevels)
to identify the type of diabetes, we did not distinguish
between type 1 and type 2 diabetes. However, we believe
that the majority of diabetes subjects in our sample are
due to type 2 diabetes mellitus. Fasting plasma glucose
levels were measured using hexokinase enzymatic method
on Roche/Hitachi Modular P Chemistry Analyzer at the
Fairview Medical Center Laboratory at the University of
Minnesota, Minneapolis MN. Random plasma glucose levels
were measured at the Collaborative Laboratory Services in
Ottumwa,IAusingtheBeckmanSynchronLX20in2007and
the Beckman Coulter UniCel DxC800 in 2008. Glycosylated
hemoglobin measurements were performed on the Tosoh
2.2 Analyzer (Tosoh Medics, Inc., 347 Oyster Pt. Boulevard,
Suite 201, So., San Francisco, Ca) in NHANES 2005-06 and
on the Automated HPLC System Glycohemoglobin Analyzer
(Tosoh Medics, Inc., 347 Oyster Pt. Blvd., Suite 201, So. San
Francisco, Ca 94080) in NHANES 2007-08 at the University
of Minnesota, Minneapolis Minnesota.
2.2. Assessment of Exposure. A questionnaire on sleep habits
based on validated questions from previous epidemiological
studies was introduced in NHANES from 2005 till 2008
[26]. SDB was assessed from a set of questions on sleep
habits including “How much sleep do you usually get at
night on weekdays or workdays?”, “In the past 12 months,
how often did you snore while you were sleeping?”, “In
the past 12 months, how often did you snort, gasp or
stop breathing while you were asleep?”, and “In the past
month, how often did you feel excessively or overly sleepy
during the day?” Based on the responses to the above
questions, we created four sleep variables: sleep duration,
snoring, snorting, and daytime sleepiness. Sleep duration
coded in hours was categorized into ≤5, 6, 7, 8, and ≥9h.
Snoringandsnortingvariableswerecategorizedintoneveror
rare, occasional (3-4 nights/week), and frequent (5 or more
nights/week). Daytime sleepiness was categorized into never
or rare, sometimes (2–4 times/month), and often or almost
always (5 or more times/month).
Based on the rationale that subjects with multiple SDB
markers (e.g., snoring, snorting, daytime sleepiness) are
likely to have more severe SDB, we developed an additive
SDB summary score to examine the eﬀect of cooccurrence
of various SDB markers in relation to diabetes mellitus. For
the summary score, we ﬁrst dichotomized the individual
variables based on their clinical signiﬁcance and previous
literature [10, 27, 28]. A score of 1 was assigned separately
if the participants report sleep duration of ≤5, snoring at
least 3-4 nights/week, snorting at least 3-4 nights/week and
daytime sleepiness at least 5 times/month. The summary
score ranged from 0 to 4 corresponding to no sleep
disturbance to coexistence of all 4 sleep disturbances. We
assessed diagnosed sleep apnea from the question, “Have
you ever been told by a doctor or other health professional
that you have a sleep disorder?” with dichotomous responses
(“yes” or “no”).
2.3. Assessment of Covariates. Information on age, gender,
race/ethnicity,smokingstatus,alcoholintake(g/day),levelof
education, history of diabetes and oral hypoglycemic intake
or insulin administration, and antihypertensive medication
use was obtained during a standardized questionnaire at
home interview. Educational attainment was categorized
into less than high school graduate, high school graduate,
and more than high school graduate. Individuals who
had smoked <100 cigarettes during their lifetime were
considered never smokers, those who had smoked ≥100
cigarettes lifetime and currently not smoking were consid-
ered former smokers, and those who had smoked ≥100
cigarettes lifetime and currently smoking were considered
current smokers. Current alcohol drinking was deﬁned as
consumption of ≥1 alcoholic drink in the past 12 months.
Moderate physical activity was deﬁned as engaging in
moderate-intensity sports, ﬁtness, or recreational activities
that cause a small increase in breathing or heart rate such
as brisk walking, bicycling, swimming, or golf for at least
10 minutes continuously in a typical week. Information on
anthropometric, physical, and laboratory components was
obtained during the medical examination center (MEC)
examination. Body weight measured in pounds using a
digital scale was converted to kilograms. Standing height was
measured using a stadiometer and corrected to the nearest
tenth of a centimeter [29]. Body mass index (BMI) was
calculated as weight in kilograms divided by heights in meter
squared. We deﬁned overweight as BMI ≥ 25kg/m2 andInternational Journal of Endocrinology 3
obesity as BMI ≥ 30kg/m2 based on the WHO international
classiﬁcation [30] and the US Centers for Disease Control
and Prevention guidelines [31]. Blood pressure (BP) was
measured using a mercury sphygmomanometer, and an
average of three measurements was taken as the systolic and
diastolic BP value. Hypertension was deﬁned as a systolic
BP ≥ 140mmHg or a diastolic BP ≥ 90mmHg or a self-
reported physician-diagnosed hypertension or current use of
BP reducing medication [32]. Depression was assessed using
the Patient Health Questionnaire (PHQ-9), a well-validated
9-itemscreeningtoolthatasksquestionsaboutthefrequency
of symptoms of depression over the past 2 weeks [33].
Depression was deﬁned as a PHQ-9 score of 10 or higher,
a validated cut-point commonly used in clinical studies [33].
Detailed description about the blood collection, process-
ing, and quality control checks are provided in the Labora-
tory Procedures Manual [34, 35]. Serum C-reactive protein
(CRP) was measured using latex-enhanced nephelometry.
Total serum cholesterol was measured enzymatically using
the Roche Hitachi 717 in 2005, Roche Hitachi 717 and 912
in 2006, and Roche Modular P chemistry analyzer in 2007-
2008.
2.4. Statistical Analysis. We compared the characteristics of
the study participants by diabetes status employing the chi
square-test or analysis of variance as appropriate. We chose
sleep duration of 7 hours as the reference category as previ-
ous studies have shown 7 hours of sleep to be associated with
lower risk of CVD and mortality [36, 37]. We examined the
association between categories of individual sleep variables,
including snoring, snorting, daytime sleepiness, and sleep
duration and diabetes in two multivariable models. In the
ﬁrst model, we adjusted for age (years) and sex (female,
male). In the second model, we additionally adjusted for
race-ethnicity (non-Hispanic whites, non-Hispanic blacks,
Hispanic Americans, others), education (< high school, high
school, > high school), smoking (never, former, current),
current alcohol consumption (absent, present), physical
activity (absent, present), body mass index (kg/m2), systolic
blood pressure (mmHg), depression (absent, present), CRP
(mg/dL), and total cholesterol (mg/dL).
ToexaminetheoveralleﬀectofSDBmarkersondiabetes,
we created an additive summary SDB score and examined
the association between this summary SDB score and
diabetes in separate analyses. Tests for trend were performed
using the categories of individual sleep variables and the
summary score as an ordinal variable in the corresponding
multivariable models. We tested for interactions between
the summary SDB score and sex, race-ethnicity, and BMI
categories by including cross-product interaction terms in
the second multivariable model. To examine the consistency
of the association we performed subgroup analyses stratiﬁed
by sex, race-ethnicity, and BMI categories. All analyses
were weighted to account for the unequal probabilities of
selection, oversampling, and nonresponse using SUDAAN
(version 8.0; Research Triangle Institute, Research Triangle
Park, NC) and SAS (version 9.1.; SAS Institute, Cary, NC)
software. In a supplementary analysis, we examined the
association between diagnosed sleep apnea and diabetes.
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Figure 1: Proportion of participants by gender and by sleep
disturbances.
3. Results
The prevalence of diabetes in the study population was 9%.
Table 1 shows the characteristics of the study population
by diabetes status. Those with diabetes were more likely
to be older, obese, had higher prevalence of hypertension,
depression and higher levels of CRP, less likely to be
non-Hispanic whites, above high school educated, current
smokers, current drinkers, physically active, and had lower
levels of total cholesterol.
Figure 1 shows the proportion of participants reporting
sleep disturbances among men and women. Men were more
likely to report snorting or snorting at least 3-4 nights/week
(both P<0.0001), and women were more likely to report
daytime sleepiness at least 5 times/month (P = 0.0002).
Table 2 shows the association between the various
sleep variables and diabetes mellitus. Compared to sleep
duration of 7h (referent), sleep duration ≤5hwaspositively
associated with diabetes in both the age-, sex-adjusted and
the multivariable models. Occasional or frequent snoring
(at least 3-4 nights/week), frequent snorting (at least 5
times/week), and frequent daytime sleepiness (at least 5
times/month) were signiﬁcantly associated with diabetes in
both the age-, sex-adjusted and the multivariable models.
A signiﬁcant graded association was observed between
increasing number of sleep disturbances and diabetes (P-
trend < 0.0001).
Table 3 shows the association between the summary
SDB score and diabetes stratiﬁed by race-ethnicity. Con-
sistent with the main results in Table 2, the association
between summary SDB score and diabetes was found to be
consistently present in all race-ethnic groups (P-interaction
between SDB score and race-ethnicity = 0.7). Table 4
shows the association between the summary SDB score and
diabetes stratiﬁed by gender. The association between the
summary SDB score and diabetes was signiﬁcant in both
men and women in the age-adjusted model, but in the4 International Journal of Endocrinology
Table 1: Baseline characteristics of the study population∗.
Characteristics Diabetes absent (n = 5685) Diabetes present (n = 837) P-value
Women (%) 2782 (50.6) 398 (50.1) 0.454
Age (years) 43.7 ±0.45 5 .4 ±0.6 <0.0001
Race/Ethnicity (%) 0.0002
Non-Hispanic Whites 2898 (73.5) 321 (63.0)
Non-Hispanic Blacks 1085 (9.4) 238 (16.8)
Mexican Americans 1021 (7.8) 185 (9.7)
Others 681 (9.3) 93 (10.4)
Education categories (%) <0.0001
Below high school 1409 (16.1) 335 (24.8)
High school 1391 (24.3) 197 (26.5)
Above high school 2885 (59.5) 305 (48.7)
Smoking (%) 0.184
Never smoker 3045 (52.9) 428 (52.1)
Former smoker 1284 (22.9) 263 (31.0)
Current smoker 1356 (24.2) 146 (16.9)
Current drinker (%) 4056 (76.3) 406 (54.0) <0.0001
Moderate physical activity (%) 2741 (54.9) 286 (39.0) <0.0001
Body mass index (%) <0.0001
Normal weight 1869 (35.2) 114 (12.1)
Overweight 2036 (34.6) 242 (26.3)
Obese 1780 (30.1) 481 (61.6)
Depression (%) 207 (3.1) 52 (6.4) 0.002
Systolic blood pressure (mmHg) 119.7 ±0.3 129.3 ±0.8 <0.0001
C-reactive protein (mg/dL) 0.4 ±0.01 0.6 ±0.04 <0.0001
Total cholesterol (mg/dL) 200.7 ±0.8 194.2 ±2.10 . 0 3
∗Data presented are number (percentages) or mean values ± standard error (SE), as appropriate for the variable.
multivariable model it was signiﬁcant in women whereas it
was substantially attenuated and not signiﬁcant in men (P-
interactionbetweenSDBscoreandsex =0.01).Inasubgroup
analysis stratiﬁed by BMI categories, the association between
summary sleep score and diabetes was consistently present
among those with BMI <25 and ≥25kg/m2. The multi-
variable odds ratio (OR) (95% conﬁdence interval (CI))
of diabetes associated with SDB summary score was 1.36
(1.05–1.77) for BMI < 25kg/m2 and 1.21 (1.09–1.34) for
BMI ≥ 25kg/m2 (P-interaction between SDB score and BMI
categories = 0.2) (data not shown).
Inasupplementaryanalysis,weexaminedtheassociation
between diagnosed sleep apnea and diabetes. 4.3% of the
participants reported having diagnosed sleep apnea. Similar
to the individual sleep variables, a signiﬁcant positive
association was observed between diagnosed sleep apnea and
diabetes. Compared to those without diagnosed sleep apnea,
the multivariable odds ratio (OR) (95% conﬁdence interval
(CI)) of diabetes among those with diagnosed sleep apnea
was 1.85 (1.19–2.89).
4. Discussion
In a representative sample of US adults, we found that
markers of SDB including short sleep duration (≤5h),
occasional or frequent snoring (at least 3-4 nights/week),
frequent snorting (at least 5 times/week), and frequent
daytime sleepiness (at least 5 times/month) were associated
withdiabetesmellitusindependentofage,sex,race-ethnicity,
education, smoking, current alcohol consumption, physical
activity, BMI, systolic blood pressure, depression, CRP
and total cholesterol. Further, an ad hoc summary SDB
score that provided a measure of the severity of SDB by
counting the cooccurrence of these four sleep disturbances
showed that, compared to those without any SDB markers,
those with three or more SDB markers had more than
twofold odds of having diabetes. In subgroup analyses, there
were no diﬀerences in this association by race-ethnicity or
by BMI categories. However, the association between the
summary SDB score and diabetes was signiﬁcant only in
women; the association was substantially attenuated and lost
statistical signiﬁcance in men after multivariable adjustment
for lifestyle and metabolic risk factors.
In the current study, we found that SDB, deﬁned by short
sleep duration, occasional or frequent snoring, frequent
snorting, and frequent daytime sleepiness was associated
with diabetes consistent with previous studies [4, 5, 7, 8,
10, 11, 15]. In the Sleep in America poll, daytime sleepiness
but not snoring, snorting, and short sleep duration were
associated with diabetes among 1506 men and women [8].
Both short and long durations of sleep were shown to be
associated with diabetes among men in the MassachusettsInternational Journal of Endocrinology 5
Table 2: Association between sleep variables and diabetes mellitus.
Sleep variables No. at risk
(n = 6522)
Diabetes cases
(n = 837)
Age-, sex-adjusted odds
ratio (95% CI)
Multivariable-adjusted
odds ratio∗ (95% CI)
Sleep duration (hours)
≤5hrs 1008 168 1.91 (1.42–2.58) 1.38 (1.01–1.90)
6hrs 1509 177 1.16 (0.89–1.53) 1.12 (0.80–1.56)
7hrs 1877 201 1 (referent) 1 (referent)
8hrs 1719 234 1.09 (0.83–1.43) 1.12 (0.83–1.51)
≥9hrs 409 57 0.91 (0.55–1.51) 0.79 (0.47–1.34)
P-trend 0.0001 0.04
Frequency of snoring
Never or rarely 3158 298 1 (referent) 1 (referent)
Occasionally 1256 184 1.93 (1.44–2.59) 1.67 (1.23–2.27)
Frequently 2108 355 1.94 (1.58–2.39) 1.44 (1.16–1.79)
P-trend <0.0001 0.0008
Frequency of snorting
Never or rarely 5718 684 1 (referent) 1 (referent)
Occasionally 421 80 1.23 (0.87–1.73) 0.94 (0.65–1.36)
Frequently 383 73 1.98 (1.48–2.66) 1.37 (1.04–1.79)
P-trend <0.0001 0.09
Frequency of daytime
sleepiness
Never or rarely 3768 481 1 (referent) 1 (referent)
Sometimes 1680 198 1.02 (0.86–1.22) 1.01 (0.81–1.25)
Often and almost always 1074 158 1.51 (1.25–1.83) 1.38 (1.08–1.76)
P-trend 0.0002 0.03
SDB summary score
0 2353 207 1 (referent) 1 (referent)
1 2573 345 1.64 (1.25–2.16) 1.37 (1.04–1.80)
2 1177 203 2.03 (1.60–2.57) 1.45 (1.14–1.85)
≥3 419 82 3.50 (2.55–4.81) 2.04 (1.46–2.87)
P-trend <0.0001 <0.0001
∗Adjusted for age (years), sex (men, women), race-ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, others), education (< high
school,highschool,>highschool),smoking(never,former,current),currentalcoholconsumption(absent,present),moderatephysicalactivity(times/week),
body mass index (kg/m2), depression (absent, present), systolic blood pressure (mmHg), C-reactive protein (mg/dL) and total cholesterol (mg/dL).
Male Aging Study [6], among participants in the ﬁrst
National Health and Nutrition Examination Survey Follow-
up Study [10], among a large cohort of participants in the
National Health Interview Survey 2004-2005 [7], and men
and women in the Sleep Heart Health Study [5]. In contrast,
intheFinnishDiabetesPreventionStudy,longsleepduration
was associated with diabetes among overweight individuals
with impaired glucose tolerance [14]. Self-reported snoring
was associated with 10-year incidence of diabetes in a large
cohort of nurses in the USA [4]. Several studies conducted
in the Europe have documented similar associations between
self-reported short sleep duration [38], snoring [11, 15], and
daytime sleepiness [15] and diabetes. Sleep duration ≤5h
was associated with 12-year incidence of diabetes in Swedish
men but not in women [38]. Snoring was associated with 10-
yearincidenceofself-reporteddiabetesin2668menaged30–
69 years in Sweden. Further, joint exposure to both snoring
and obesity had a ﬁvefold odds of diabetes compared with
their absence [11]. In a cross-sectional study in Finland, self-
reported snoring but not daytime sleepiness was associated
with diabetes among 593 men and women [15].
Our study contributes to the existing literature on SDB
by demonstrating, in detailed subgroup analyses, that the
SDB-diabetesassociation(1)wasconsistentlypresentinboth
non-Hispanic whites and other race-ethnicities, but that (2)
there were sex-related diﬀerences in this association. First,
to our knowledge, this is the ﬁrst population-based study
thatcomparedtheassociationbetweenSDBanddiabetesside
by side by race-ethnicity as previous studies were conducted
either in predominantly white samples or samples involving
only African Americans and Hispanic Americans.
Second, in the subgroup analysis by sex, we found
that even though there was a positive association between
SDB markers and diabetes in both sexes in the initial age-
adjusted model, upon multivariable adjustment for lifestyle
and metabolic risk factors, the association was no longer6 International Journal of Endocrinology
Table 3: Association between SDB and diabetes mellitus, by race/ethnicity.
SDB summary score No. at risk Diabetes cases Age-, sex-adjusted odds ratio (95% CI) Multivariable-adjusted odds ratio∗ (95% CI)
Non-Hispanic Whites
0 1209 84 1 (referent) 1 (referent)
1 1242 131 1.73 (1.17–2.55) 1.42 (0.94–2.14)
2 566 74 2.12 (1.48–3.03) 1.48 (1.06–2.07)
≥3 202 32 3.94 (2.40–6.48) 2.21 (1.42–3.45)
P-trend <0.0001 <0.0001
Other race-ethnicities
0 1144 123 1 (referent) 1 (referent)
1 1331 214 1.40 (1.07–1.83) 1.25 (0.91–1.70)
2 611 129 1.75 (1.22–2.51) 1.38 (0.91–2.10)
≥3 217 50 2.46 (1.52–3.99) 1.73 (0.98–3.06)
P-trend <0.0001 0.03
∗Adjusted for age (years), sex (men, women), education (< high school, high school, > high school), smoking (never, former, current), current alcohol
consumption (absent, present), moderate physical activity (times/week), body mass index (kg/m2), depression (absent, present), systolic blood pressure
(mmHg), C-reactive protein (mg/dL), and total cholesterol (mg/dL).
P-interaction (SDB summary score × race-ethnicity) = 0.7.
Table 4: Association between SDB and diabetes mellitus, by gender.
SDB summary score No. at risk Diabetes cases Age-adjusted odds ratio (95% CI) Multivariable-adjusted odds ratio∗ (95% CI)
Men
0 1065 109 1 (referent) 1 (referent)
1 1360 180 1.56 (1.17–2.09) 1.38 (1.03–1.86)
2 683 114 1.91 (1.32–2.76) 1.42 (0.96–2.09)
≥3 234 36 1.82 (1.12–2.94) 1.10 (0.59–2.04)
P-trend 0.0001 0.25
Women
0 1288 98 1 (referent) 1 (referent)
1 1213 165 1.68 (1.17–2.43) 1.31 (0.87–2.00)
2 494 89 2.06 (1.51–2.82) 1.48 (0.99–2.20)
≥3 185 46 6.03 (3.65–9.96) 3.68 (2.01–6.72)
P-trend <0.0001 <0.0001
∗Adjusted for age (years), race-ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, others), education (< high school, high school,
> high school), smoking (never, former, current), current alcohol consumption (absent, present), moderate physical activity (times/week), body mass index
(kg/m2), depression (absent, present), systolic blood pressure (mmHg), C-reactive protein (mg/dL), and total cholesterol (mg/dL).
P-interaction (SDB summary score f × female) = 0.01.
present in men whereas strongly present in women. This
ﬁnding indirectly suggests that the role of SDB in men is
explained by lifestyle and metabolic risk factors such as
BMI, lack of physical activity, depression, high CRP, and
others where as in women SDB has a residual association
that is independent of these factors. Finally, our ﬁnding
of an independent association in women but not in men
is consistent with some [9, 17, 39] but not all previous
studies [13]. For example, in the Cardiovascular Health
Study, involving 5201 men and women aged ≥65 years in the
USA, snoring was associated with diabetes in older women
but not in older men [9]. In the MONICA study involving
7905 men and women, snoring was associated with diabetes
only in women [17]. In a clinic-based study involving 318
menandwomenaged30–69yearsinSweden,SDBdeﬁnedby
polysomnographic measured overnight oxygen desaturation
was associated with diabetes in women but not in men [39].
In contrast, in a cross-sectional study involving 1396 men
and 1500 women aged 45–74 years in Finland, self-reported
SDB was associated with diabetes in middle-aged men but
not in women [13].
Several mechanisms have been proposed to explain
the association between SDB and diabetes. Epidemiological
studies have shown that short sleep duration is associated
with altered glucose metabolism [40], poor glycemic control
[41], insulin resistance [40], and markers of inﬂammation
[42]. Snoring with resultant intermittent hypoxia leads
to insulin resistance and diabetes [43] through a variety
of mechanisms, including activation of the sympathetic
nervous system resulting in elevated catecholamine levels
[44], activation of the hypothalamic-pituitary-adrenal axis
resultinginelevatedcortisollevels[45],formationofreactive
oxygen species and increased oxidative stress [46], and
activation of proinﬂammatory cytokines [47].International Journal of Endocrinology 7
The large multiethnic sample with rich information on
potential confounders and the rigorous methodology of
data collection in NHANES are the main strengths of the
study. Our study has some limitations. First, assessment of
SDB from self-reported sleep measures might have resulted
in nondiﬀerential misclassiﬁcation biasing the association
towards null. Second, even though we adjusted for obesity
in the multivariable analysis and also performed stratiﬁed
analysis by BMI categories, it is possible that there is residual
confounding by obesity status which may be biasing our
results. Third, it is possible that some of the markers that
we use to deﬁne SDB are biased. For example, there may be
gender and/or racial diﬀerences in the self-report of snoring.
Without polysomnographic examination, it is diﬃcult to
avoid measurement error due to self-report. Fourth, our
ﬁndingsaregeneralizableonlytotheUSnoninstitutionalized
civilian population; the results may not be representative
of institutionalized people or populations outside the USA.
Fifth, our cross-sectional study design limits making conclu-
siononthetemporalassociationsbetweenSDBanddiabetes.
In conclusion, in a nationally representative sample
of US adults, we found that sleep duration ≤5h, occa-
sional or frequent snoring, frequent snorting, and frequent
daytime sleepiness were associated with diabetes mellitus
independent of potential confounders. This association was
signiﬁcant only in women but consistently present in all
ethnic groups.
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